Main Article Content

Covid-19 Vaccine Acceptance and Risk Perception in Ghana: Insights from A Study on Tertiary-Level Students and Surrounding Residents in Kumasi


Dr. Samuel Nkansah Darko
Dr. Kennedy Gyau Boahen
Ms. Portia Boakye Okyere
Mr. Christopher Nii Kpakpo Addo
Ms. Ameyaw Afuaa Janet
Mr. Hayford Manuella
Ms. Anwhere Naomi Efua
Dr (Mrs) Sandra Abankwa Kwarteng

Abstract

The introduction of COVID-19 vaccines in sub-Saharan Africa has been met with mixed feelings. In Ghana, several concerns were raised about the potency and side effects of the COVID-19 vaccine. We investigated the acceptance and risk perception of students on the KNUST campus and the residents of the surrounding communities to assess the risk factors that will influence their willingness or unwillingness to be vaccinated in the government’s quest to get its citizens vaccinated. A well-structured questionnaire was administered online and through face-to- face interviews to survey 3332 respondents between the periods of March 15 and May 28, 2021. Chi-square analysis was used to show the association between the sociodemographic characteristics and, the acceptance and risk perception of the COVID-19 vaccine. Logistic regression analysis was used to explain the relationship between the acceptance and risk perception of the COVID-19 vaccine and the various socio-demographic characteristics. Out of 3323 respondents, 1,703 (45.23%) were hesitant whiles 64.39% of 3311 indicated they would accept being vaccinated. In a multivariate analysis, the age range of 31 to 40 years, being male, having secondary level education, and having a previous vaccination post-childhood immunization increased the likelihood of vaccine acceptance. More than half of the students of KNUST and inhabitants around the campus are likely to acceptant the COVID-19 vaccine. However, adequate and timely information is needed to educate prospective vaccine recipients with tertiary level education to better the level of acceptance and address misinformation about vaccines and promote individual and population-level benefits of vaccination.


Journal Identifiers


eISSN: 3057-3629
print ISSN: 0855-0395